Sat.Jul 24, 2021 - Fri.Jul 30, 2021

Social health: The future of healthcare marketing

Bio Pharma Dive

Approximately 79% of patients look to connect through social media to find answers to their health questions

HCPs use of digital

World of DTC Marketing

SUMMARY: 62% of HCPs spend 3 hours per day accessing digtal resources. More HCPs chose to use smartphones to access digital resources as well and usage has increased when accessing a wide variety of professional content.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The State of Pediatric Clinical Research: An Interview with Paidion CEO Barry Mangum, PharmD, FCP


Barry Mangum talks the importance of pediatric research, its evolution over the years, and the obstacles and opportunities that the industry faces as it moves forward. How long have you been in pediatric clinical research, and how did you enter the field?

Beware using telemedicine for voice and speech therapy


As a result of the coronavirus pandemic, people across the world have experienced how teleconferencing platforms like Zoom help folks stay connected—playing games with friends, hosting virtual weddings, and even visiting a doctor.

Bluebird preps for split by selling manufacturing plant to well-funded startup

Bio Pharma Dive

The startup manufacturing specialist National Resilience, which raised $800 million when it launched last year, will pay Bluebird $110 million for the North Carolina facility, bringing its North American network up to 10

Blaming the anti-vaxxers is not the answer

World of DTC Marketing

SUMMARY: Anti-vaxxers are vocal, and the media amplify their voices. There are many reasons why people aren’t getting vaccinated. We need more data to understand why. Republican extremism is part of the problem, but so is the lack of education.

More Trending

Scientists model ‘true prevalence’ of COVID-19 throughout pandemic


Credit: Rebecca Gourley/University of Washington Government officials and policymakers have tried to use numbers to grasp COVID-19’s impact. Figures like the number of hospitalizations or deaths reflect part of this burden. Each datapoint tells only part of the story.

A biotech startup raises $117M to deliver gene therapies in a new way

Bio Pharma Dive

Flagship Pioneering, the biotech incubator that created Moderna, is helping fund Ring Therapeutics, a startup hoping to disrupt gene therapy development through the use of a different viral vector

How to choose the right digital agency

World of DTC Marketing

INTRODUCTION: One of the most important factors in your digital initiatives’ success, or failure, is the agency you choose. A lot of agencies are competing for our business.

A Rationally Designed Therapeutic Vaccine for Herpes


The designation was awarded for RVx201, a live-attenuated therapeutic vaccine the company is developing for genital herpes resulting from the herpes simplex type 2 (HSV-2) virus

Improving air quality reduces dementia risk, multiple studies suggest


Credit: Alzheimer’s Association DENVER, JULY 26, 2021 — Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported today at the Alzheimer’s Association International Conference® (AAIC®) 2021 in Denver and virtually.

A pharma merger's impact ripples across West Virginia as Viatris plant closes

Bio Pharma Dive

One of the country's oldest and largest drug manufacturing plants will shut down Saturday, a casualty of the 2019 merger between Mylan and Pfizer's Upjohn unit. The impact will be felt by a West Virginia city for years to come

Rapid COVID immune status test launched in UK, Ireland

Pharma Phorum

You’ve had your two COVID-19 jabs, but are you actually protected against infection? That’s a question that a fingerprick test launched today in the UK and Ireland could help to answer.

EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds

Pharma Times

Study in adolescents met it primary endpoint, successfully bridging immune responses to those observed in an efficacy study in adults

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy


FDA rejects a biotech's kidney drug, but some analysts still see a 'sliver of hope'

Bio Pharma Dive

The agency wants Ardelyx to run another trial to show its drug affects clinical outcomes for patients with chronic kidney disease. Analysts think this could be accomplished, but would take some time

Trials 259

8 Best Cities In The US Offering Biotech Jobs


Biotech jobs are one of the most promising career paths for people who are into life sciences and those who dream of creating change in the world through developing breakthrough medicines and therapeutics

AstraZeneca and mRNA COVID-19 vaccines ‘show similar safety profiles’

BioPharma Reporter

A study of more than a million vaccinated people has found 'similar safety profiles' for the AstraZeneca and Pfizer/BioNTech vaccines: adding the incidence of rare blood clots was far higher among people with COVID-19 than those who had received either vaccine. Bio Developments

Elsevier partners with American College of Medical Genetics and Genomics to publish Genetics in Medicine


Bristol Myers withdraws Opdivo in liver cancer as fallout from FDA meeting continues

Bio Pharma Dive

With the decision by Bristol Myers, each of the two accelerated cancer drug approvals an FDA advisory panel voted to overturn in April have now been voluntary withdrawals

Drugs 262

Pfizer-BioNTech Vaccine: African Deal, $34 Billion in Sales, and Efficacy Drop


?Pfizer has reported several highlights regarding its mRNA COVID-19 vaccine. As the world deal with rising Delta variant cases, Pfizer-BioNTech is still arguing that a third booster shot will be likely

Sales 101

Why digital doctors are crucial for the future of primary care

Pharma Phorum

Our primary care system is weathering a storm on several fronts. Demand is skyrocketing, with GPs delivering millions more appointments than in previous years and workload far outstripping pre-Covid-19 levels.

Juicy past of favorite Okinawan fruit revealed


Merck rebounds to win a milestone immunotherapy approval in early breast cancer

Bio Pharma Dive

The FDA reversed an earlier decision to make Keytruda the first immunotherapy available for patients with early-stage breast cancer and also gave the drugmaker a full approval in advanced disease


T Cells: The Forgotten Warrior in the COVID-19 Battle


The T cell response was measured with immunoSEQ® T-MAP™ COVID, a clinical test developed by Adaptive Biotechnologies

Google’s DeepMind puts human proteome online for free

Pharma Phorum

The most complete database of protein structures ever assembled, developed with the help of Google’s artificial intelligence unit DeepMind, has been made freely available to researchers around the world.

Extreme heat, dry summers main cause of tree death in Colorado’s subalpine forests


Credit: Robert Andrus Even in the absence of bark beetle outbreaks and wildfire, trees in Colorado subalpine forests are dying at increasing rates from warmer and drier summer conditions, found recent University of Colorado Boulder research.

In a first, FDA approves an 'interchangeable' biosimilar for diabetes

Bio Pharma Dive

An injectable insulin from Viatris has become the first-ever biosimilar product that can be directly substituted for a marketed biologic, a long-awaited decision that could put pricing pressure on other diabetes drugs

Keytruda Rebounds in TNBC and Wins Approval for High-Risk, Early-Stage Patients


Merck's Keytruda won FDA approval for the treatment of patients with high-risk, early-stage triple-negative breast cancer. The approval marked the 30th for Keytruda

Health literacy in the time of COVID-19

Pharma Phorum

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important. Impetus Digital’s N atalie Yeadon explores why.

New US and German collaboration aims to produce green hydrogen more efficiently


Credit: University of Illinois/Technical University of Darmstadt Through a new award program, the U.S.